Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2025-12-25 @ 8:16 PM
Study NCT ID:
NCT01622569
Status:
COMPLETED
Last Update Posted:
2018-12-26
First Post:
2012-06-13
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety
Sponsor:
Optinose US Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-11-19
Start Date Type:
ACTUAL
Primary Completion Date:
2015-08-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-10-01
Completion Date Type:
ACTUAL
First Submit Date:
2012-06-13
First Submit QC Date:
None
Study First Post Date:
2012-06-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-10-17
Results First Submit QC Date:
None
Results First Post Date:
2018-12-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-09-27
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-12-04
Last Update Post Date:
2018-12-26
Last Update Post Date Type:
ACTUAL